Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,402.00p
   
  • Change Today:
      38.00p
  • 52 Week High: 3,170.00p
  • 52 Week Low: 1,924.00p
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 172,753
  • Market Cap: £1,598.28m
  • RiskGrade: 128
  • Beta: 0.01

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
11-May-26 Berenberg Bank Buy - 3,350.00p 3,350.00p Reiteration
16-Jan-26 Shore Capital Buy 2,835.00p - 3,000.00p Reiteration
16-Jan-26 Deutsche Buy 2,835.00p 3,100.00p 3,300.00p Reiteration
16-May-23 Peel Hunt Limited Buy 2,544.00p - 4,500.00p Reiteration
07-Dec-21 Liberum Capital Buy 4,948.00p - 5,740.00p Reiteration
29-Jun-21 Citigroup Hold 4,972.00p 5,500.00p 5,500.00p Reiteration
29-Jun-21 Numis Add 4,972.00p - 5,500.00p Reiteration
06-Dec-18 Kepler Capital Markets Buy 2,386.00p 2,475.00p 2,630.00p Upgrade
30-Oct-17 N 1 Singer Buy 2,430.00p 1,844.00p 2,485.00p Upgrade
04-Aug-16 HSBC Buy 1,907.00p - 2,200.00p Reiteration
12-May-15 Numis Securities Hold - - 1,410.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Genus Market Data

Currency UK Pounds
Share Price 2,402.00p
Change Today 38.00p
% Change 1.61 %
52 Week High 3,170.00p
52 Week Low 1,924.00p
Volume 172,753
Shares Issued 66.54m
Market Cap £1,598.28m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 2
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Mar-26 06-Nov-25
Paid 27-Mar-26 05-Dec-25
Amount 11.20p 21.70p

Trades for 15-May-2026

Time Volume / Share Price
16:37 26,000 @ 2,379.92p
16:50 2,049 @ 2,388.92p
16:47 716 @ 2,379.59p
16:37 26,000 @ 2,379.92p
16:35 49,175 @ 2,402.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page